Brivaracetam Impurity 2 CAS 357336-19-7

Description

Compared with other compounds in its class, the molecular weight of 212.29 g/mol gives Brivaracetam Impurity 2 distinctive chromatographic separation conditions and mass-spectrometry parameter settings.

Brivaracetam Impurity 2 (CAS 357336-19-7) is a certified pharmaceutical impurity reference standard with the molecular formula C11H20N2O2 and a molecular weight of 212.29 g/mol.

The molecular framework of Brivaracetam Impurity 2 (C11H20N2O2) is characterized by an amino-acid-derived structure, an amide group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by its high hydrophobicity (logP), which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The high carbon-to-hydrogen ratio imparts good lipophilicity, allowing liquid-liquid extraction with non-polar solvents such as n-hexane or ethyl acetate.

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

CATO manufactures Brivaracetam Impurity 2 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Why CATO?

• ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
• 130,000+ catalog items in stock, COA supplied with every batch
• Worldwide shipping with full export documentation (HS code guidance available)
• Technical support: +86 18665070610 / Nicole.chen@cato-chem.com